Estimated Control (33%) Closed Transaction verified Beauty & Personal CareCPGK BeautySkincare

Dr. Jart+ acquired by The Estée Lauder Companies

The Estée Lauder Companies acquired Dr. Jart+, a South Korea beauty & personal care brand on Nov 18, 2019. FundComb records estimated consideration of USD 1.9bn. The current comp implies EV / revenue of 3.8x. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.

Transaction summary

Target
Dr. Jart+
Acquirer
The Estée Lauder Companies
Seller
-
Announced
2019-11-18
Geography
South Korea
Tags
Beauty & Personal CareCPGK BeautySkincare
Type
Acquisition
Deal type
Control
Stake acquired
33%
First added
2026-06-18
Latest update
2026-06-18

Value and multiples

Price / value

USD 1.9B

Transaction value | USD

Basis: FundComb estimate

EV / revenue

3.8x

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • USD 1.9bn transaction value is a FundComb estimate. Public sources reviewed confirm the transaction, but do not independently disclose every valuation input.
  • Implied EV / revenue is 3.8x, calculated from USD 1.9bn value and USD 501m revenue.
  • Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.

Source summary

No public source summary has been published for this transaction yet.